• OPEN AN ACCOUNT
Indian Indices
Sensex
80,056.92 746.91
( 0.94%)
Global Indices
Nasdaq
51,872.69 -1,504.43
(-2.82%)
Dow Jones
7,442.16 -267.46
(-3.47%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,776.27 -52.94
(-0.49%)
Forex
USD-INR
94.59 -0.14
(-0.15%)
EUR-INR
106.30 0.31
(0.29%)
GBP-INR
127.42 0.36
(0.28%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
43.29
83.19
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

dlf ltd
Remsons Industries slides as CEO Amit Srivastava resigns
Jun 19,2026

According to the company's regulatory filing, Srivastava submitted his resignation letter on June 18, 2026. He will continue to perform his duties and responsibilities during the mandatory 90-day notice period.

The company stated that the resignation will become effective upon completion of the notice period or on any other mutually agreed date between the company and Srivastava.

The company clarified that disclosures relating to profile and relationships between directors are not applicable in the case of the resignation.

Remsons Industries manufactures auto components such as auto control cables, flexible shafts, gear shift systems, push-pull cables, and parking brake mechanisms. The company exports primarily to the UK, Europe, North America, Brazil, Mexico, and SAARC countries.

The company’s consolidated net profit fell 95.28% to Rs 3.09 crore in Q4 FY26 as against Rs 65.51 crore in Q4 FY25. Revenue from operations rose 22.81% YoY to Rs 130.40 crore in Q4 FY26 over Q4 FY25.